News - Amgen

Filter

Current filters:

Amgen

Popular Filters

50 to 74 of 145 results

Amgen and Astellas link up on drugs for unmet medical needs in Japan

29-05-2013

World leading independent biotech firm Amgen (Nasdaq: AMGN) has joined forces with Japanese drug major…

AmgenAnti-Arthritics/RheumaticsAsia-PacificAstellas PharmaBiotechnologyCardio-vascularOncologyPharmaceuticalResearch

Routine cinacalcet for end stage kidney disease not warranted

01-05-2013

Cinacalcet, a drug commonly given to patients with end stage kidney disease to help keep phosphorus and…

AmgenBiotechnologycinacalcetNephrology and HepatologyPharmaceuticalResearchSensipar

Amgen profit leaps 21%, but 1st-qtr revenues disappoint

24-04-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, posted first-quarter 2013…

AmgenBiotechnologyFinancial

Amgen to pay $24.9 million to resolve false claims on Aranesp marketing

17-04-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has agreed to pay the…

AmgenAranespBiotechnologyFinancialLegalNorth America

Amgen's talimogene laherparepvec Ph III trial in melanoma meets endpoint

21-03-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has presented positive…

AmgenBiotechnologyOncologyResearchtalimogene laherparepvec

Switch to anabolics driving osteoporosis market growth

11-03-2013

A major paradigm shift in late and mid-stage product development from anti-resorptive therapies to anabolic…

AmgenAnti-Arthritics/RheumaticsMarkets & MarketingPharmaceuticalromosozumabUCB

FDA suspends pediatric trial of Amgen's Sensipar after patient death

27-02-2013

The US Food and Drug Administration revealed yesterday that it has stopped all pediatric clinical trials…

AmgenBiotechnologyRegulationResearchSensipar

UCB and Amgen not to progress development of romosozumab for fracture healing

13-02-2013

Belgium's leading drugmaker UCB (Euronext Brussels: UCB) and its partner, US biotech giant Amgen (Nasdaq:…

AmgenAnti-Arthritics/RheumaticsBiotechnologyPharmaceuticalResearchromosozumabUCB

Amgen raises 2013 forecast, outlines strategy

08-02-2013

World leading independent biotech firm Amgen (Nasdaq: AMGN) yesterday outlined the company's long-term…

AmgenBiotechnologyFinancialMarkets & Marketing

US biotech giants lobbying to block biosimilars, NTY claims

31-01-2013

Some of the USA's biggest biotechnology companies are lobbying intensively to limit generic competition…

AmgenBiotechnologyGenentechGenericsNorth AmericaPoliticsRegulation

Amgen 4th-qtr net profit plunges 16% but sales up; gets boost from fiscal cliff legislation

24-01-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest biotechnology firm, posted financials after markets…

AmgenBiotechnologyFinancialNorth AmericaPricingSensipar

Amgen's Aranesp fails in heart patients; to invest $200 million in Singapore

18-01-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, announced top-line results…

AmgenAranespAsia-PacificBiotechnologyCardio-vascularProductionResearch

DSM licenses XD cell culture patents to Amgen

15-01-2013

DSM Pharmaceutical Products, the custom manufacturing and technology business of Netherlands-based Royal…

AmgenBiotechnologyDSMDSM BiologicsLicensingProduction

Amgen in $180 mill deal with BIND; Priaxon accord with GlaxoSmithKline

09-01-2013

BIND Biosciences, a US clinical stage investor backed company, and Amgen (Nasdaq: AMNG), the world's…

AmgenBIND BiosciencesBiotechnologyGlaxoSmithKlineLicensingOncologyPharmaceuticalPriaxon

FDA approves SOBI's Kineret for the treatment of NOMID

08-01-2013

Biotech firm Swedish Orphan Biovitrum (STO: SOBI) today announced that the US Food and Drug Administration…

AmgenBiotechnologyInflammatory diseasesKineretNorth AmericaRegulationSobiSwedish Orphan Biovitrum

Licensing deals for Amgen/ImmunoGen and Shire/Arrowhead

20-12-2012

US biotechnology company ImmunoGen (Nasdaq), which develops anticancer therapeutics using its Targeted…

AmgenArrowhead ResearchBiotechnologyImmunoGenLicensingOncologyPharmaceuticalRare diseasesShire

50 to 74 of 145 results

Company Spotlight

Fibrotech

Fibrotech

Back to top